Literature DB >> 10330026

Antigen-induced hyperreactivity to histamine: role of the vagus nerves and eosinophils.

R W Costello1, C M Evans, B L Yost, K E Belmonte, G J Gleich, D B Jacoby, A D Fryer.   

Abstract

M2 muscarinic receptors limit acetylcholine release from the pulmonary parasympathetic nerves. M2 receptors are dysfunctional in antigen-challenged guinea pigs, causing increased vagally mediated bronchoconstriction. Dysfunction of these M2 receptors is due to eosinophil major basic protein, which is an antagonist for M2 receptors. Histamine-induced bronchoconstriction is composed of a vagal reflex in addition to its direct effect on airway smooth muscle. Because hyperreactivity to histamine is seen in antigen-challenged animals, we hypothesized that hyperreactivity to histamine may be due to increased vagally mediated bronchoconstriction caused by dysfunction of M2 receptors. In anesthetized, antigen-challenged guinea pigs, histamine-induced bronchoconstriction was greater than that in control guinea pigs. After vagotomy or atropine treatment, the response to histamine in antigen-challenged animals was the same as that in control animals. In antigen-challenged animals, blockade of eosinophil influx into the airways or neutralization of eosinophil major basic protein prevented the development of hyperreactivity to histamine. Thus hyperreactivity to histamine in antigen-challenged guinea pigs is vagally mediated and dependent on eosinophil major basic protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330026     DOI: 10.1152/ajplung.1999.276.5.L709

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  23 in total

Review 1.  Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.

Authors:  Bart C Moulton; Allison D Fryer
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

2.  Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction.

Authors:  Allison D Fryer; Louis H Stein; Zhenying Nie; Damian E Curtis; Christopher M Evans; Simon T Hodgson; Peter J Jose; Kristen E Belmonte; Erin Fitch; David B Jacoby
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

Review 3.  Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis.

Authors:  Seema S Aceves; Steven J Ackerman
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

4.  Inhibition of neuronal M(2) muscarinic receptor function in the lungs by extracellular nitric oxide.

Authors:  L Golkar; K A Yarkony; A D Fryer
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

5.  Vagotomy reverses established allergen-induced airway hyperreactivity to methacholine in the mouse.

Authors:  M Allen McAlexander; Stephen H Gavett; Marian Kollarik; Bradley J Undem
Journal:  Respir Physiol Neurobiol       Date:  2015-04-01       Impact factor: 1.931

Review 6.  Airway Innervation and Plasticity in Asthma.

Authors:  L E M Kistemaker; Y S Prakash
Journal:  Physiology (Bethesda)       Date:  2019-07-01

Review 7.  Airway smooth muscle in the pathophysiology and treatment of asthma.

Authors:  Diana C Doeing; Julian Solway
Journal:  J Appl Physiol (1985)       Date:  2013-01-10

8.  Hyperinsulinemia potentiates airway responsiveness to parasympathetic nerve stimulation in obese rats.

Authors:  Zhenying Nie; David B Jacoby; Allison D Fryer
Journal:  Am J Respir Cell Mol Biol       Date:  2014-08       Impact factor: 6.914

9.  Atropine-enhanced, antigen challenge-induced airway hyperreactivity in guinea pigs is mediated by eosinophils and nerve growth factor.

Authors:  Norah G Verbout; David B Jacoby; Gerald J Gleich; Allison D Fryer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-15       Impact factor: 5.464

Review 10.  Eosinophil function in allergic inflammation: from bone marrow to tissue response.

Authors:  Darryl Adamko; Paige Lacy; Redwan Moqbel
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.